Modified Benjamin Graham Formula

We take a look at how the Benjamin Graham Formula over-estimates the value of stocks (in our opinion). Read More...
Comments

Growth Oriented Restaurant Stocks - Buffalo Wild Wings Looks Most Attractive

In this article we look at growth-oriented restaurant stocks that have shown strong EPS growth over the past 5 years to see if we can find any that would make attractive investments.
Growth Oriented Restaurant Stocks - Buffalo Wild Wings Looks Most Attractive
Read More...
Comments

EBIX Valuation

What growth rates justify EBIX's current price? Read More...
Comments

Value Meals: Dividends and Value in the Restaurant Business

ZenPrime recently screened stocks looking for those with value plus dividends in the restaurant industry.
Value Meals: Dividends and Value in the Restaurant Business Read More...
Comments

Garmin: Value Stock or Value Trap?

Is Garmin at its current price a Value Stock or a Value Trap?
Garmin: Value Stock or Value Trap? Read More...
Comments

Growth and Value: RIM Stands Out in Smartphone Market

Looking solely at the fundamentals and intrinsic value of the stocks, we analyzed Apple, Google (GOOG) and Research in Motion (RIMM) to see if any of these appears to be undervalued.
Growth and Value: RIM Stands Out in Smartphone Market
Read More...
Comments

Four Value Stocks in the Home Healthcare Industry

The rise in obesity, an aging population, longer life spans of Americans—these and other factors might indicate the home health care industry has good long-term prospects for investment. Four home healthcare providers analyzed using ZenValue to determine which would be the best investment based on their fundamentals.
Four Value Stocks in the Home Healthcare Industry Read More...
Comments

Chinese Online Game and Internet Service Companies: Reviewing Values and Fundamentals

ZenPrime reviews our holdings in the online gaming and internet services industry in China to see if there are better values out there.
Chinese Online Game and Internet Service Companies: Reviewing Values and Fundamentals Read More...
Comments

Which Indian Outsourcer Is the Best Buy: Cognizant, Wipro or Infosys?

ZenPrime looks at CTSH and two other Indian outsourcers -- Wipro Ltd. (WIT) and Infosys Technologies, Ltd. (INFY) -- and compare their relative strengths based on fundamentals.
Which Indian Outsourcer Is the Best Buy: Cognizant, Wipro or Infosys? Read More...
Comments

Eye on Payday Lenders

2010 brought new laws regulating to a certain extent how payday lenders operate. We decided to look into three of these companies and see what the impacts, if any, have been, and whether or not there are any payday lender-type stocks that seem undervalued out there.
Eye on Payday Lenders Read More...
Comments

Valuation of Healthcare Information Systems & Software Providers

With the constant pressure on health care costs one would think that information systems and software and solutions providers that promise to streamline the processing of medical records would be attractive companies to invest in. Using ZenValue software, we decided to analyze five of these companies to see if they provided an attractive investment on both a growth and valuation basis.
The five companies we looked at are : Athenahealth, Inc (
ATHN); Cerner Corp. (CERN); McKesson Corp. (MCK); and Allscripts Heathcare Solutions, Inc. (MDRX), Quality Systems, Inc. (QSII). Using the analysts's average 5-year projected growth rates for each company, the output gave us the following for price vs. intrinsic value for each company (sorted in ascending order).

810007-129395528387563-ZenPrime-Software

The trailing 5-years FCF per share growth rate of each of the 5 companies is below for reference:
ATHN: 20% (4 years of data), CERN: 17%, MCK: 8%, MDRX: 65%; QSII: 24%.
The initial pass shows MCK to be priced at 70% of intrinsic value, CERN priced close to intrinsic value, and the others at a premium of 40% to 70% of intrinsic value.

The valuation page has the following highlights:

810007-129395674302783-ZenPrime-Software
The PEG ratio of all companies is greater than one. Looking at most ratios, MCK seems to be the most fairly priced of these stocks. The price/sales ratio of 0.14 stands out and needs further looking into, though.

The return on investments page has the following highlights:


810007-129396154984689-ZenPrime-Software

QSII is head and shoulders above the other companies with ROIC consistently above 20% for the last 5 years. However, ROIC has been steadily declining over the last 3 years from a high of close to 35%. The ROIC of CERN and MCK has held steady or grown over the last few years, although running around half that of QSII.

810007-129396188128959-ZenPrime-Software810007-129396191620817-ZenPrime-Software


Finally, the debt and liquidity page has the following highlights:

810007-129396238626433-ZenPrime-Software

Only MCK and MDRX have significant debt. That of MDRX has declined over the past 5 years from a high of 0.8, while MCK's debt has actually risen from a low of 0.15 to its current level. Also, MCK's current ratio is less than 1, and has been for the last 5 years, which might indicate problems paying their current liabilities.

810007-129396243275335-ZenPrime-Software810007-129396249752469-ZenPrime-Software

In summary, among the stocks we've looked at in the information systems/software and solutions providers for the healthcare industry, only one company seems selling at a discount to its intrinsic value: MCK. However there are other issues around the company's rising debt and ability to pay its obligations that are causes for concern or at least monitoring. CERN seems to combine a fair value with a decent growth rate and no red flags in the areas we looked at. QSII has a very high ROIC and decent growth rate, but that comes at quite a premium to its intrinsic value.
 
ZenPrime has no positions in any of the stocks discussed above, and no plans to create positions in the next 90 days.
Comments
Panoramic theme by ThemeFlood